Trademark Search in Canada

PLEXI-T

View On IC.GC.CA

FORMALIZED

on 6 Feb 2025

Last Applicant/ Owned by

TScan Therapeutics, Inc.

830 Winter StreetWaltham, MA 02451

Serial Number

2378707 filed on 6^th Feb 2025

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

H3B1S6

PLEXI-T

Trademark usage description

cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of ca Read More

Classification Information

Class [005]
Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer

Classification kind code

Class [042]
Pharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer

Classification kind code

Mark Details

Serial Number

2378707

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 30 on 6^th Feb 2025	Filed
Submitted for opposition 1 on 6^th Feb 2025	Created
Submitted for opposition 31 on 6^th Feb 2025	Formalized

PLEXI-T

Classification Information

Class [005]Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer

Classification kind code

Class [042]Pharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer

Class [042]
Pharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer